SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Brigham and Women's Hospital at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Brigham and Women's Hospital brings 8 presentations to SITC 2026 in Phoenix. Its program centres on macrophages and other myeloid cells in tumors, including engineered monocytes used as cell therapy, along with career and grant advice for trainees. One distinctive item explores how a patient's age shapes breast cancer immunity, treatment response and outcomes.

OrganizationSITC 2026 Attendance
Cancer centres & hospitals
Harvard-affiliated academic medical center in Boston, part of Mass General Brigham.
Session
Thu Nov 5
12:00pm–1:30pm
Workshop
Thu Nov 5
2:30pm–5:05pm
Grant Writing Workshop
  1. 2:30pm–4:30pmSession I – Grant Writing Essentials
  2. 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates
  3. 4:30pm–5:00pmSession II – Breakout Sessions
  4. 5:00pm–5:05pmClosing
Session
Fri Nov 6
1:45pm–3:25pm
Oral Abstract Session 1
  1. 1:46pm–2:00pmPremalignant oral dysplasias that progress to cancer are distinguished by spatially organized T cell responsesGladstone-UCSF Institute of Genomic Immunology
  2. 2:00pm–2:14pmFirst-in-Human Clinical Trial for Breast Cancer Leptomeningeal Disease Induces Adaptive Immunity and Transcriptomic Immune Remodelling in the Cerebral Spinal FluidMoffitt Cancer Center
  3. 2:14pm–2:28pmSpatiotemporal Immune Remodeling Under Neoadjuvant Pembrolizumab in Mismatch Repair–Deficient Endometrial CancerUniversity Medical Center Groningen
  4. 2:28pm–2:42pmThe function and therapeutic potential of intratumoral Tregs in cancer.University of California, Berkeley
  5. 2:42pm–2:56pmE. coli Dual-Function Immunometabolic Engagers (DIME-12) Enhance Local Anti-Tumor Immunity and Reprogram the Immunometabolic NicheDana-Farber Cancer Institute
  6. 2:56pm–3:10pmLongitudinal multimodal immune profiling reveals targetable inflammatory endotypes and predictive entropy dynamics underlying immune related adverse eventsFrancis Crick Institute
  7. 3:10pm–3:24pmICB-driven dynamic TME evolution dictates clinical response and guides combination therapiesSun Yat-sen University Cancer Center
Session
Sat Nov 7
3:30pm–4:50pm
New Avenues in Myeloid Cells
Tumor biology
  1. 3:30pm–3:50pmLeveraging Single-Cell Technologies to Engineer the Immune SystemWeizmann Institute of Science
  2. 3:50pm–4:10pmNeutrophils as Architects of the Tumor Microenvironment: From Vascular Occlusion to MetastasisJohns Hopkins University
  3. 4:10pm–4:30pmLILRB CheckpointsMassachusetts General Hospital
  4. 4:30pm–4:40pmComprehensive multimodal mapping of intrinsic and external modulators of monocyte trogocytosis of tumor cellsUniversity of Oxford
  5. 4:40pm–4:50pmPreclinical efficacy and safety of Z-007, a first-in-class RNA/DNA TLR7/8/9 agonist, in mouse tumor models, spontaneous canine cancers, nonhuman primates, and human tumor-associated immune cells.Zola Therapeutics
Talk
Sat Nov 7
6:20pm–6:40pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Brigham and Women's Hospital

Tell us what you sell and we’ll find the people at Brigham and Women's Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction